A 35-year-old woman presents with 4 months of amenorrhea, increased FSH, LH, and decreased estrogen. What is the most likely diagnosis?

Premature ovarian insufficiency

In the transition from a Graafian follicle to a functional corpus luteum, which of the following cellular events occurs?

Granulosa cells begin to express LH receptors

Granulosa cells begin to express estrogen receptors

Theca cells begin to express androgen receptors

Granulosa cells begin to express progesterone receptors

Which of the following is NOT characteristic of menopause?

There is a marked decrease in adrenal cortical estrogen secretion

Systemic vasomotor instability may be present

There may be an increase in FSH secretion by the pituitary gland

There is a decrease in skin elasticity

Physiology of Menopause for FMGE: High-Yield Obstetrics and Gynecology Lessons

Definition & Ovarian Aging - Ovary's Swan Song

Menopause: Permanent cessation of menses (≥12 months amenorrhea), no pathological cause.
Perimenopause: Transition before menopause; irregular cycles, hormonal fluctuations (↑FSH, variable ↓Estrogen).
Postmenopause: Period after Final Menstrual Period (FMP).
Ovarian Aging:
- Key: Progressive ovarian follicular (oocyte) depletion via atresia.
- Results in:
  - ↓ Inhibin B → ↑FSH (early, key marker).
  - ↓ Estrogen (later).
  - ↑LH.
- ↓ Anti-Müllerian Hormone (AMH): Early indicator of declining ovarian reserve.

⭐ Average age of natural menopause in Indian women is around 46-47 years, slightly earlier than Western counterparts (global average ~51 years).

Hormonal Changes - Endocrine Shuffle

Primary Event: Ovarian follicular depletion (oocyte & granulosa cell loss).
Key Hormonal Shifts:
- ↓ Estrogen (E2): Leads to menopausal symptoms. Initially fluctuates, then sustained low.
- ↓ Progesterone: Due to anovulation.
- ↓ Inhibin B: Early marker; its fall causes ↑FSH.
- ↓ Anti-Müllerian Hormone (AMH): Reflects ovarian reserve; declines early.
- ↑ FSH: Most sensitive marker; rises due to ↓estrogen & ↓inhibin feedback. Levels >30-40 mIU/mL are indicative.
- ↑ LH: Rises, but less than FSH.
📌 Mnemonic: FSH/LH High, Estrogen/Progesterone/Inhibin/AMH Low (FLH H EPLIA L).

Hormone levels in reproductive phase and menopause

⭐ A serum FSH level consistently >30-40 mIU/mL (with some labs using >25 mIU/mL) in conjunction with 12 months of amenorrhea is a key biochemical indicator of menopause.

Systemic Consequences - Estrogen's Echo

Estrogen withdrawal impacts multiple organ systems due to loss of its protective effects.

Organ System	Key Changes & Pathophysiology (Estrogen ↓ leads to...)
Vasomotor	Hot flushes, night sweats. Hypothalamic thermoregulatory instability (neurotransmitter imbalance: ↑Norepinephrine, ↓Serotonin).
Urogenital	Genitourinary Syndrome of Menopause (GSM): vaginal atrophy (dryness, dyspareunia), recurrent UTIs. ↓Collagen, ↓vascularity, ↑vaginal pH.
Skeletal	Osteoporosis, ↑fracture risk. ↑RANKL/OPG ratio → ↑osteoclast activity, ↑bone resorption, ↓Bone Mineral Density (BMD).
Cardiovascular	↑Coronary Artery Disease risk. Adverse lipids (↓HDL, ↑LDL, ↑Triglycerides), endothelial dysfunction, ↑inflammation.
CNS	Mood swings, sleep disturbances, "brain fog". Altered serotonin, norepinephrine levels, direct neuronal impact.
Skin & Hair	Skin thinning, ↓elasticity, hair loss. ↓Collagen synthesis, altered dermal matrix.

Estrogen deficiency effects on bone and oral health

High‑Yield Points - ⚡ Biggest Takeaways

Depletion of ovarian follicles is the primary event leading to menopause.

↓ Estrogen and ↓ Inhibin B cause a significant ↑ FSH and ↑ LH.

Elevated FSH (>30-40 mIU/mL) is the most reliable endocrine marker.

Estrone (E1) becomes the predominant estrogen, synthesized from androstenedione in peripheral adipose tissue.

Ovaries continue to produce androgens (e.g., androstenedione, testosterone) post-menopause.

Key symptoms include vasomotor instability (hot flashes) and urogenital atrophy due to estrogen deficiency_._

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play